# IntelliProve

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/intelliprove

- Industry: Healthcare IT
- Headquarters: Belgium
- Website: www.intelliprove.com
- Total disclosed funding: $0.8M
- Latest round: Seed (Nov 14, 2022)
- Investors on record: 3

## About

Based in Gent, Belgium, and founded in 2021 by CEO Joeri Tulkens, CFO Maxime Mattelin, CTO Brecht Dhuyvetters, and CSO Tanguy Sanglet, IntelliProve BV operates as a med-tech company providing a platform that enables doctors and mental health practitioners to patient consultations by using the smartphone camera to determine their condition. In January 2025, IntelliProve BV raised EUR 1.25 million in venture funding from new investor Miles Ahead, with participation from returning investors Wit-Gele Kruis and imec.istart. Individual investors also participated in the round.

IntelliProve BV provides a processing engine that allows users to deduct the blood flow in the face using the camera from a mobile device and measure health parameters. The company offers health insights such as respiratory rate and mental health risks through ROI detection, biomedical signal selection, signal processing, and other health parameters. In addition, the firm provides a mental health assessment algorithm for artificial intelligence-based mental checks. 

The company will use the January 2025 funding to support IntelliProve achieve its purpose of enabling health and wellbeing solutions that can utilize objective insights and improve preventive holistic health.

## Funding rounds

- Seed, Nov 14, 2022, $0.8M — imec.istart, Agentschap Innoveren & Ondernemen, Wit-Gele Kruis

## Investors

- imec.istart — Seed
- Agentschap Innoveren & Ondernemen (https://capitalatlas.ai/funds/agentschap-innoveren-ondernemen) — Seed
- Wit-Gele Kruis — Seed